GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 63 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $18,040 | -61.3% | 12,528 | -43.5% | 0.00% | – |
| Q1 2023 | $46,574 | -53.4% | 22,178 | -74.9% | 0.00% | – |
| Q4 2022 | $99,931 | +244.6% | 88,434 | +387.5% | 0.00% | – |
| Q3 2022 | $29,000 | +107.1% | 18,140 | +69.5% | 0.00% | – |
| Q2 2022 | $14,000 | -62.2% | 10,700 | -53.1% | 0.00% | – |
| Q1 2022 | $37,000 | -85.3% | 22,800 | -81.2% | 0.00% | – |
| Q4 2021 | $251,000 | -49.2% | 121,282 | -4.8% | 0.00% | – |
| Q3 2021 | $494,000 | +98.4% | 127,332 | +63.7% | 0.00% | – |
| Q2 2021 | $249,000 | +369.8% | 77,800 | +217.6% | 0.00% | – |
| Q1 2021 | $53,000 | -70.7% | 24,500 | -69.8% | 0.00% | – |
| Q4 2020 | $181,000 | +64.5% | 81,233 | +97.2% | 0.00% | – |
| Q3 2020 | $110,000 | -28.6% | 41,200 | -18.1% | 0.00% | – |
| Q2 2020 | $154,000 | -14.9% | 50,283 | -45.6% | 0.00% | – |
| Q1 2020 | $181,000 | -19.6% | 92,503 | +17.7% | 0.00% | – |
| Q4 2019 | $225,000 | -43.5% | 78,591 | -27.5% | 0.00% | – |
| Q3 2019 | $398,000 | +45.8% | 108,346 | +64.9% | 0.00% | – |
| Q2 2019 | $273,000 | -46.3% | 65,700 | -34.0% | 0.00% | – |
| Q1 2019 | $508,000 | +9.5% | 99,511 | -26.4% | 0.00% | – |
| Q4 2018 | $464,000 | -33.3% | 135,127 | +16.8% | 0.00% | – |
| Q3 2018 | $696,000 | +4.2% | 115,700 | +10.2% | 0.00% | – |
| Q2 2018 | $668,000 | +39.2% | 104,999 | +3.6% | 0.00% | – |
| Q1 2018 | $480,000 | +177.5% | 101,346 | +95.6% | 0.00% | – |
| Q4 2017 | $173,000 | +284.4% | 51,800 | +144.3% | 0.00% | – |
| Q3 2017 | $45,000 | -72.7% | 21,200 | -68.4% | 0.00% | – |
| Q2 2017 | $165,000 | -20.7% | 67,000 | -25.9% | 0.00% | – |
| Q1 2017 | $208,000 | +447.4% | 90,409 | +134.2% | 0.00% | – |
| Q4 2016 | $38,000 | -34.5% | 38,600 | -25.3% | 0.00% | – |
| Q3 2016 | $58,000 | +190.0% | 51,671 | +273.5% | 0.00% | – |
| Q2 2016 | $20,000 | -4.8% | 13,836 | +57.1% | 0.00% | – |
| Q3 2015 | $21,000 | -27.6% | 8,809 | -18.2% | 0.00% | – |
| Q2 2015 | $29,000 | +20.8% | 10,766 | +55.9% | 0.00% | – |
| Q4 2014 | $24,000 | -76.2% | 6,906 | -65.5% | 0.00% | – |
| Q3 2014 | $101,000 | +173.0% | 20,018 | +642.0% | 0.00% | – |
| Q2 2014 | $37,000 | – | 2,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |